Cargando…

Preparation, Characterization, and Bioactivity Evaluation of Polyoxymethylene Copolymer/Nanohydroxyapatite-g-Poly(ε-caprolactone) Composites

In this work, nanohydroxyapatite (HAp) was functionalized with poly(ε-caprolactone) (PCL), using 1,6-hexamethylene diisocyanate (HDI) as a coupling agent, and then incorporated into the polyoxymethylene copolymer (POM) matrix using the extrusion technique. The obtained POM/HAp-g-PCL composites were...

Descripción completa

Detalles Bibliográficos
Autores principales: Pielichowska, Kinga, Szuba, Paula, Maciocha, Joanna, Macherzyńska, Beata, Nowicka, Katarzyna, Szatkowski, Piotr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912578/
https://www.ncbi.nlm.nih.gov/pubmed/35269346
http://dx.doi.org/10.3390/nano12050858
_version_ 1784667174783156224
author Pielichowska, Kinga
Szuba, Paula
Maciocha, Joanna
Macherzyńska, Beata
Nowicka, Katarzyna
Szatkowski, Piotr
author_facet Pielichowska, Kinga
Szuba, Paula
Maciocha, Joanna
Macherzyńska, Beata
Nowicka, Katarzyna
Szatkowski, Piotr
author_sort Pielichowska, Kinga
collection PubMed
description In this work, nanohydroxyapatite (HAp) was functionalized with poly(ε-caprolactone) (PCL), using 1,6-hexamethylene diisocyanate (HDI) as a coupling agent, and then incorporated into the polyoxymethylene copolymer (POM) matrix using the extrusion technique. The obtained POM/HAp-g-PCL composites were investigated using FTIR, DSC, TOPEM DSC, and TG methods. Mechanical properties were studied using destructive and non-destructive ultrasonic methods, wettability, and POM crystallization kinetics in the presence of HAp-g-PCL. Moreover, preliminary bioactivity evaluation of the POM/HAp-g-PCL composites was performed using the Kokubo method. It was found that the introduction of HAp-g-PCL to the POM matrix has a limited effect on the phase transitions of POM as well as on its degree of crystallinity. Importantly, HAp grafted with PCL caused a significant increase in the thermal stability of the POM, from 292 °C for pristine POM to 333 °C for POM modified with 2.5% HAp-g-PCL. If unmodified HAp was used, a distinct decrease in the thermal stability of the POM was observed. Crystallization kinetic studies confirmed that HAp-g-PCL, in small amounts, can act as a nucleating agent for the POM crystallization process. Moreover, incorporation of HAp-g-PCL, although slightly decreasing the mechanical properties of POM composites, improved the crucial parameter in biomedical applications, namely the in vitro bioactivity.
format Online
Article
Text
id pubmed-8912578
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89125782022-03-11 Preparation, Characterization, and Bioactivity Evaluation of Polyoxymethylene Copolymer/Nanohydroxyapatite-g-Poly(ε-caprolactone) Composites Pielichowska, Kinga Szuba, Paula Maciocha, Joanna Macherzyńska, Beata Nowicka, Katarzyna Szatkowski, Piotr Nanomaterials (Basel) Article In this work, nanohydroxyapatite (HAp) was functionalized with poly(ε-caprolactone) (PCL), using 1,6-hexamethylene diisocyanate (HDI) as a coupling agent, and then incorporated into the polyoxymethylene copolymer (POM) matrix using the extrusion technique. The obtained POM/HAp-g-PCL composites were investigated using FTIR, DSC, TOPEM DSC, and TG methods. Mechanical properties were studied using destructive and non-destructive ultrasonic methods, wettability, and POM crystallization kinetics in the presence of HAp-g-PCL. Moreover, preliminary bioactivity evaluation of the POM/HAp-g-PCL composites was performed using the Kokubo method. It was found that the introduction of HAp-g-PCL to the POM matrix has a limited effect on the phase transitions of POM as well as on its degree of crystallinity. Importantly, HAp grafted with PCL caused a significant increase in the thermal stability of the POM, from 292 °C for pristine POM to 333 °C for POM modified with 2.5% HAp-g-PCL. If unmodified HAp was used, a distinct decrease in the thermal stability of the POM was observed. Crystallization kinetic studies confirmed that HAp-g-PCL, in small amounts, can act as a nucleating agent for the POM crystallization process. Moreover, incorporation of HAp-g-PCL, although slightly decreasing the mechanical properties of POM composites, improved the crucial parameter in biomedical applications, namely the in vitro bioactivity. MDPI 2022-03-03 /pmc/articles/PMC8912578/ /pubmed/35269346 http://dx.doi.org/10.3390/nano12050858 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pielichowska, Kinga
Szuba, Paula
Maciocha, Joanna
Macherzyńska, Beata
Nowicka, Katarzyna
Szatkowski, Piotr
Preparation, Characterization, and Bioactivity Evaluation of Polyoxymethylene Copolymer/Nanohydroxyapatite-g-Poly(ε-caprolactone) Composites
title Preparation, Characterization, and Bioactivity Evaluation of Polyoxymethylene Copolymer/Nanohydroxyapatite-g-Poly(ε-caprolactone) Composites
title_full Preparation, Characterization, and Bioactivity Evaluation of Polyoxymethylene Copolymer/Nanohydroxyapatite-g-Poly(ε-caprolactone) Composites
title_fullStr Preparation, Characterization, and Bioactivity Evaluation of Polyoxymethylene Copolymer/Nanohydroxyapatite-g-Poly(ε-caprolactone) Composites
title_full_unstemmed Preparation, Characterization, and Bioactivity Evaluation of Polyoxymethylene Copolymer/Nanohydroxyapatite-g-Poly(ε-caprolactone) Composites
title_short Preparation, Characterization, and Bioactivity Evaluation of Polyoxymethylene Copolymer/Nanohydroxyapatite-g-Poly(ε-caprolactone) Composites
title_sort preparation, characterization, and bioactivity evaluation of polyoxymethylene copolymer/nanohydroxyapatite-g-poly(ε-caprolactone) composites
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912578/
https://www.ncbi.nlm.nih.gov/pubmed/35269346
http://dx.doi.org/10.3390/nano12050858
work_keys_str_mv AT pielichowskakinga preparationcharacterizationandbioactivityevaluationofpolyoxymethylenecopolymernanohydroxyapatitegpolyecaprolactonecomposites
AT szubapaula preparationcharacterizationandbioactivityevaluationofpolyoxymethylenecopolymernanohydroxyapatitegpolyecaprolactonecomposites
AT maciochajoanna preparationcharacterizationandbioactivityevaluationofpolyoxymethylenecopolymernanohydroxyapatitegpolyecaprolactonecomposites
AT macherzynskabeata preparationcharacterizationandbioactivityevaluationofpolyoxymethylenecopolymernanohydroxyapatitegpolyecaprolactonecomposites
AT nowickakatarzyna preparationcharacterizationandbioactivityevaluationofpolyoxymethylenecopolymernanohydroxyapatitegpolyecaprolactonecomposites
AT szatkowskipiotr preparationcharacterizationandbioactivityevaluationofpolyoxymethylenecopolymernanohydroxyapatitegpolyecaprolactonecomposites